# Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ai-25-012-rational-design-of-vaccines-against-hepatitis-c-virus/  
Official notice: https://www.grants.gov/search-results-detail/359143

> National Institutes of Health offered grants of up to $2.0 million to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on November 7, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-25-012 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 7, 2025 |
| Award ceiling | $2.0 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.855 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.

## What the grant funds

The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus to enable the advancement of vaccine candidates into clinical evaluation.

## Questions people ask

### Is RFA-AI-25-012 still open?

No. It closed on November 7, 2025.

### Who can apply for Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)?

Closed November 7, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $2.0 million each.

### Who has been funded under RFA-AI-25-012?

NIH RePORTER lists 3 projects funded under RFA-AI-25-012 in fiscal 2026, at 3 institutions. The most were at Emory University, Johns Hopkins University, The Scripps Research Institute.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.